-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Teniposide is a chemotherapy drug that is used to treat various types of cancer, including leukemia, lymphoma, and solid tumors.
It is classified as an anthracycline antibiotic and works by interfering with the ability of cancer cells to produce proteins necessary for their growth and survival.
The production and use of teniposide is an important part of the chemical industry, and understanding the upstream and downstream products of teniposide is essential for optimizing its production and ensuring its quality.
Upstream products of teniposide include the raw materials needed to produce the drug, such as the bacteria from which it is extracted.
The most commonly used bacteria for the production of teniposide are Streptomyces verticillus and Streptomyces callosus.
These bacteria are cultured in large fermentation tanks, where they are grown on a nitrogen-limited medium to promote the production of the desired compounds.
The culture supernatant is then collected and purified to obtain the active ingredient, teniposide.
Another upstream product of teniposide is the enzymes that are used in its production.
These enzymes are used to convert the precursor compound, deoxyribonucleoside, into teniposide.
The most commonly used enzymes are DNA deaminases and phosphorylases, which are derived from bacteria such as Escherichia coli and Bacillus subtilis.
The enzymes are usually produced by recombinant DNA technology in microorganisms such as E.
coli or yeast, and they are purified and concentrated before use in the production of teniposide.
Downstream products of teniposide include the various forms of the drug that are used for treatment, such as tablets, capsules, and intravenous solutions.
These products are produced by pharmaceutical companies that purchase the active ingredient from manufacturers and then formulate it into the desired dosage forms.
The final product is then tested for quality and efficacy before being released to the market.
Another downstream product of teniposide is its use in research and development.
The drug is used as a model compound in studies aimed at understanding the mechanisms of action of anti-cancer drugs and developing new therapies.
In addition, teniposide is used as a positive control in toxicology studies to assess the safety and efficacy of new drugs.
In conclusion, upstream products of teniposide include the bacteria and enzymes used in its production, while downstream products include the various forms of the drug and its use in research and development.
Understanding the upstream and downstream products of teniposide is crucial for optimizing its production, ensuring its quality, and developing new therapies to treat cancer.